Prescription/Rx Sunglass Market Worth $3.76 Billion By 2022: Grand View Research, Inc.

Emerging new product streams along with changing consumer demographics are expected to drive gains. In addition, growing coverage for vision care with recent healthcare initiatives has expanded pool of insured eye care. Technological advancements are largely expected to impact the prescription sunglass market in both lens material and lens design adoption.

Growing global population and vision deficiency has opened up several new opportunities for Rx sunglass market manufacturers and retailers. Growing popularity of Internet based sales transactions due to widespread adoption of e-commerce industry is expected to increase the revenue inflow from the cyberspace over the forecast period.

Grand View Research has segmented the prescription/Rx sunglass market on the basis of lens material and region:

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco . The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email: sales@grandviewresearch.com
Web: